Corbus Pharmaceuticals' Series A Round

Corbus Pharmaceuticals raised a round of funding on April 23, 2014. Investors include Ascent Biomedical Ventures.

Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic d…

Articles about Corbus Pharmaceuticals' Series A Round: